Xenon Pharmaceuticals XENE Cash Flow Statement (2013-2026)

NASDAQ XENE
$37.25 +0.53 (+1.44%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Xenon Pharmaceuticals Quarterly Cash Flow Statement

Periods 52 quarters
Latest Jun 2026

Xenon Pharmaceuticals reported cash from operations of -$95.39M and free cash flow of -$95.67M for the quarter ended Jun 2026, down 48.5% year over year. This cash flow statement covers 52 quarters of results from Sep 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-15.45M-25.56M-19.67M-31.16M-37.15M-37.40M-41.73M-47.46M-48.46M-44.74M-47.93M-57.92M-62.79M-65.69M-65.05M-84.71M-90.90M-105.26M-102.30M-110.74M
Share-based Compensation
2.64M2.71M3.61M5.21M5.74M5.81M5.99M8.45M8.74M9.18M9.40M14.72M13.00M13.60M12.17M13.71M13.71M14.12M16.89M16.73M
Deferred Taxes
-0.27M0.35M0.26M-0.10M-0.20M0.01M0.29M-0.22M-0.16M-0.20M0.40M-0.33M-0.32M-8.61M-1.21M-0.17M-0.70M-1.11M0.45M-1.94M
Cash from Operations
-15.01M-20.71M-18.43M-16.87M-30.40M-35.33M-34.41M-33.22M-48.08M-35.40M-46.19M-31.15M-49.66M-54.38M-61.65M-64.23M-71.75M-81.48M-88.90M-95.39M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.21M0.27M0.38M0.38M0.36M0.30M0.35M0.60M1.73M-0.63M0.59M0.64M0.67M0.67M0.66M0.63M0.64M0.61M0.59M0.56M
Change in Working Capital
Change in Receivables
0.33M-0.48M0.15M-0.39M-0.01M-1.51M-0.23M-0.04M-0.15M0.29M-0.04M0.02M0.08M0.55M7.18M
Change in Accured Expenses
-1.27M3.76M-5.80M5.79M2.06M6.02M-0.59M5.58M-3.36M2.30M-5.02M9.15M-1.79M6.18M-3.78M0.87M5.23M3.19M-1.80M5.72M
Other Working Capital Changes
-0.82M-2.20M0.27M-0.71M4.47M6.47M-2.93M-1.27M0.10M2.53M0.67M-1.26M-0.66M0.03M0.93M5.49M3.37M-6.59M1.48M2.50M
Investing Activities
Capital Expenditures
0.22M0.51M0.21M0.54M0.39M1.75M2.21M2.13M1.20M0.08M0.19M1.51M0.59M0.78M0.04M0.16M0.28M0.32M0.13M0.28M
Cash from Investing Activities
15.57M-215.43M-48.89M1.32M-234.10M-11.74M46.62M27.90M53.88M-239.79M-43.19M109.19M0.50M98.50M34.51M82.26M38.53M62.70M-407.28M-331.24M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Equity Issued and Repurchased
0.03M0.01M7.88M277.07M-29.47M0.05M1.15M0.07M2.36M1.39M5.49M0.03M
Misc.
Cash from Financing Activities
4.76M323.95M7.88M269.89M0.70M0.01M324.01M12.13M1.15M0.07M2.36M113.54M843.01M0.03M
Exchange Rate Effect
-0.45M0.07M0.29M-0.89M-2.70M0.81M0.06M0.36M-0.29M0.25M-0.37M-0.20M0.05M-1.16M-0.06M0.63M-0.01M-0.10M-0.13M0.26M
Change in Cash
4.88M87.88M-59.15M253.45M-266.50M-46.25M12.27M-4.96M35.02M49.07M-89.75M77.84M-49.11M55.09M-26.05M18.72M-30.87M94.65M346.70M-426.34M
Free Cash Flow
-15.23M-21.22M-18.64M-17.41M-30.79M-37.08M-36.62M-35.35M-49.28M-35.48M-46.38M-32.67M-50.26M-55.17M-61.70M-64.39M-72.03M-81.80M-89.03M-95.67M
Net Cash Flow
5.33M87.81M-59.44M254.34M-263.80M-47.06M12.21M-5.32M5.80M48.82M-89.38M78.04M-49.17M56.25M-25.99M18.09M-30.86M94.75M346.83M-426.60M

Xenon Pharmaceuticals Cash Flow Statement API

Pull Xenon Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XENE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY